As of 2021, 27 per cent of drug shortages in the US are due to supply chain issues. As pharmaceutical supply chains reel under the expectations and pressure of the pandemic, drug shortages have skyrocketed over the past couple of years. 

The pharma supply chain is quite complex with several stakeholders including manufacturers, wholesale distributors, and PBMs. Considering multiple bottlenecks like logistics, regulations, and distribution now is the time to redesign pharmaceutical supply chains.